Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial

BACKGROUND: Many cancer patients who receive chemotherapy experience adverse drug effects. Pharmacogenomics (PGx) has promise to personalize chemotherapy drug dosing to maximize efficacy and safety. Fluoropyrimidines and irinotecan have well-known germline PGx associations. At our institution, we ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Reizine, Natalie, Vokes, Everett E., Liu, Ping, Truong, Tien M., Nanda, Rita, Fleming, Gini F., Catenacci, Daniel V.T., Pearson, Alexander T., Parsad, Sandeep, Danahey, Keith, van Wijk, Xander M. R., Yeo, Kiang-Teck J., Ratain, Mark J., O’Donnell, Peter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750903/
https://www.ncbi.nlm.nih.gov/pubmed/33414846
http://dx.doi.org/10.1177/1758835920974118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750903/
https://www.ncbi.nlm.nih.gov/pubmed/33414846
http://dx.doi.org/10.1177/1758835920974118

Ejemplares similares